CTRI/2019/11/021977尚未招募4 期
Comparative efficacy of Andrographis paniculata and Metformin to Metformin Monotherapy in Glycemic control in Newly Diagnosed, Treatment- naïve Type 2 Diabetes patients
Dr Anand Kumar Maurya0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a.Patients with 18-60 years of age.
- •b.Newly diagnosed patients with Type-2 Diabetes Mellitus as defined by the International Diabetes Federation (IDF) guidelines 2017. (Aschner, 2017) (Refer Appendix II).
- •c.Written informed consent
排除标准
- •a.Patient not willing to give informed consent.
- •b.Patients of Type I Diabetes Mellitus.
- •c.Patients with history of angina attack, heart failure, myocardial infarction.
- •d.Patients with history of cerebrovascular accidents.
- •e.Subjects on Insulin therapy
- •f.Subjects having liver & renal disease.
- •g.Subject having respiratory disease.
- •h.Subject having inflammatory disease.
- •i.Subject having genetic disorder.
- •j.Subject having HIV disease.
- •k.Subjects having any type of cancer.
- •l.Subjects having bacterial and viral infections.
- •m.Patient on other medication (hypoglycemic, steroids, hypolipidemic etc.) multidrug antihypertensive therapy.
- •n.Patients suffering from major medical/surgical illness.
- •o.Hypersensitivity to any of the used drugs.
- •p.Patient with autoimmune disease (like as multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), or other conditions)
- •q.Pregnant and lactating female,Female plan for Pregnancy
研究者
相似试验
进行中（未招募）
4 期
Comparison of Andrographis paniculata to standard treatment for relieve symptoms in common coldAndrographis paniculataStandard treatmentCommon coldTCTR20201204001none200
已完成
3 期
The efficacy and safety of Andrographis paniculata extract for the treatment of acute nonspecific upper respiratory tract infections: a randomized double-blind placebo controlled trialAcute nonspecific upper respiratory tract infections with one or more symptoms such as fever,sore throat,nasal congestion,dry infrequent cough and had modified Centor Score of 2 or less.Andrographis paniculataandrographolideacute nonspecific upper respiratory tract infectionspharyngitiscommon coldTCTR20170329002Department of Thai Traditional and Alternative Medicine829
已完成
1 期
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trialTCTR20210708001Thai Traditional Medicine Knowlegde funding63
招募中
3 期
Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trialCOVID-19 patienrs, RT-PCR confirmedCovid-19 treatmentAndrographidis paniculatae extractPneumoniaTCTR20211224002Health System Research Institute736
已完成
2 期
Comparison efficacy and safety of Andrographis paniculata extract capsules and placebo in COVID-19 patients: Double blind randomized control trialCOVID-19 patient with asymptomatic and mild symptomatic. Progression score between 0-3. (Green color)COVID-19AndrographolideTCTR20210809004Thammasat university186